Human virus-specific CD8+ T cells: Diversity specialists

Immunological Reviews

Volumn 211, Issue , 2006, Pages 225-235

  Van Leeuwen, Ester M M ^a   De Bree, Godelieve J ^a   Ten Berge, Ineke J M ^a   Van Lier, René A W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD45RA ANTIGEN; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; VIRUS ANTIGEN;

ANTIVIRAL ACTIVITY; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG DESIGN; EFFECTOR CELL; EPSTEIN BARR VIRUS; FOLLOW UP; HEPATITIS B; HEPATITIS C; HERPES VIRUS; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; LATENT VIRUS INFECTION; LYMPHOCYTE DIFFERENTIATION; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TISSUE DISTRIBUTION; VACCINATION; VIRUS INFECTION; VIRUS LATENCY; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIGENIC VARIATION; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; VIRUSES;

EID: 33745113482     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2006.00379.x     Document Type: Review

References (89)

1. Kaech SM Wherry EJ Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002 2: 251 262.
2. Welsh RM Selin LK Szomolanyi-Tsuda E. Immunological memory to viral infections. Annu Rev Immunol 2004 22: 711 743.
3. Kaech SM Tan JT Wherry EJ Konieczny BT Surh CD Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003 4: 1191 1198.
4. Huster KM, et al. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc Natl Acad Sci USA 2004 101: 5610 5615.
5. Wherry EJ Barber DL Kaech SM Blattman JN Ahmed R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc Natl Acad Sci USA 2004 101: 16004 16009.
6. Appay V, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002 8: 379 385.
7. van Lier RA ten Berge IJ Gamadia LE. Human CD8(+) T-cell differentiation in response to viruses. Nat Rev Immunol 2003 3: 931 939.
8. Altman JD, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996 274: 94 96.
9. Callan MF, et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998 187: 1395 1402.
10. Hislop AD Annels NE Gudgeon NH Leese AM Rickinson AB. Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med 2002 195: 893 905.
11. Catalina MD Sullivan JL Brody RM Luzuriaga K. Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells. J Immunol 2002 168: 4184 4191.
12. Roos MT, et al. Changes in the composition of circulating CD8+ T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans. J Infect Dis 2000 182: 451 458.
13. Appay V, et al. Dynamics of T cell responses in HIV infection. J Immunol 2002 168: 3660 3666.
14. Wills MR Okecha G Weekes MP Gandhi MK Sissons PJ Carmichael AJ. Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response. J Immunol 2002 168: 5455 5464.
15. Gamadia LE Remmerswaal EB Weel JF Bemelman F van Lier RA ten Berge IJ. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 2003 101: 2686 2692.
16. Thimme R Oldach D Chang KM Steiger C Ray SC Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001 194: 1395 1406.
17. Lechner F, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000 191: 1499 1512.
18. Urbani S, et al. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J Virol 2002 76: 12423 12434.
19. Rentenaar RJ, et al. Development of virus- specific CD4(+) T cells during primary cytomegalovirus infection. J Clin Invest 2000 105: 541 548.
20. Trowbridge IS Thomas ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 1994 12: 85 116.
21. Smith SH Brown MH Rowe D Callard RE Beverley PC. Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology 1986 58: 63 70.
22. Springer TA Lasky LA. Cell adhesion. Sticky sugars for selectins. Nature 1991 349: 196 197.
23. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999 286: 2098 2102.
24. Forster R, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999 99: 23 33.
25. Chen G, et al. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 2001 98: 156 164.
26. Fry TJ Mackall CL. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 2005 174: 6571 6576.
27. Schluns KS Kieper WC Jameson SC Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000 1: 426 432.
28. Tan JT Ernst B Kieper WC LeRoy E Sprent J Surh CD. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 2002 195: 1523 1532.
29. Prlic M Lefrancois L Jameson SC. Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J Exp Med 2002 195: F49 F52.
30. Janeway CA Bottomly K. Signals and signs for lymphocyte responses. Cell 1994 76: 275 285.
31. June CH Bluestone JA Nadler LM Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994 15: 321 331.
32. Linsley PS Bradshaw J Urnes M Grosmaire L Ledbetter JA. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. J Immunol 1993 150: 3161 3169.
33. Goodwin RG, et al. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 1993 73: 447 456.
34. Hintzen RQ Lens SM Beckmann MP Goodwin RG Lynch D van Lier RA. Characterization of the human CD27 ligand, a novel member of the TNF gene family. J Immunol 1994 152: 1762 1773.
35. Arens R, et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 2001 15: 801 812.
36. Hendriks J Gravestein LA Tesselaar K van Lier RA Schumacher TN Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 2000 1: 433 440.
37. Hintzen RQ de JR Lens SM Brouwer M Baars P van Lier RA. Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol 1993 151: 2426 2435.
38. van Leeuwen EM, et al. IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood 2005 106: 2091 2098.
39. Sanders ME, et al. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J Immunol 1988 140: 1401 1407.
40. Novak TJ Farber D Leitenberg D Hong SC Johnson P Bottomly K. Isoforms of the transmembrane tyrosine phosphatase CD45 differentially affect T cell recognition. Immunity 1994 1: 109 119.
41. Bell EB Sparshott SM. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 1990 348: 163 166.
42. Kuijpers TW, et al. Frequencies of circulating cytolytic, CD45RA+CD27-, CD8+ T lymphocytes depend on infection with CMV. J Immunol 2003 170: 4342 4348.
43. Sylwester AW, et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005 202: 673 685.
44. Langeveld M Gamadia LE ten Berge IJM. T lymphocyte subset distribution in human spleen. Eur J Clin Invest ( in press).
45. van Stipdonk MJ Lemmens EE Schoenberger SP. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol 2001 2: 423 429.
46. Arens R, et al. Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation. J Exp Med 2004 199: 1595 1605.
47. Gamadia LE, et al. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J Immunol 2004 172: 6107 6114.
48. Papagno L, et al. Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors. Clin Exp Immunol 2002 130: 509 517.
49. Park JH, et al. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 2004 21: 289 302.
50. Appay V Rowland-Jones SL. Lessons from the study of T-cell differentiation in persistent human virus infection. Semin Immunol 2004 16: 205 212.
51. de Bree GJ, et al. Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons. J Infect Dis 2005 191: 1710 1718.
52. He XS, et al. Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses. J Infect Dis 2003 187: 1075 1084.
53. Lucas M, et al. Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells. J Immunol 2004 172: 1744 1753.
54. He XS, et al. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 1999 96: 5692 5697.
55. Ogg GS, et al. Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression. J Virol 1999 73: 9153 9160.
56. Gamadia LE, et al. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood 2001 98: 754 761.
57. Khan N, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002 169: 1984 1992.
58. Kern F, et al. Distribution of human CMV- specific memory T cells among the CD8pos: subsets defined by CD57, CD27, and CD45 isoforms. Eur J Immunol 1999 29: 2908 2915.
59. Sandberg JK Fast NM Nixon DF. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes. J Immunol 2001 167: 181 187.
60. Boutboul F, et al. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS 2005 19: 1981 1986.
61. Paiardini M, et al. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol 2005 174: 2900 2909.
62. Kobayashi N Takata H Yokota S Takiguchi M. Down-regulation of CXCR4 expression on human CD8+ T cells during peripheral differentiation. Eur J Immunol 2004 34: 3370 3378.
63. Hamann D, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997 186: 1407 1418.
64. Sallusto F Lenig D Forster R Lipp M Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999 401: 708 712.
65. Masopust D Vezys V Marzo AL Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001 291: 2413 2417.
66. Reinhardt RL Khoruts A Merica R Zell T Jenkins MK. Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001 410: 101 105.
67. Ellefsen K Harari A Champagne P Bart PA Sekaly RP Pantaleo G. Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections. Eur J Immunol 2002 32: 3756 3764.
68. Ravkov EV Myrick CM Altman JD. Immediate early effector functions of virus-specific CD8+CCR7+ memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers. J Immunol 2003 170: 2461 2468.
69. Wherry EJ, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003 4: 225 234.
70. Unsoeld H Krautwald S Voehringer D Kunzendorf U Pircher H. Cutting edge: CCR7+ and CCR7- memory T cells do not differ in immediate effector cell function. J Immunol 2002 169: 638 641.
71. Sallusto F, et al. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 1999 29: 2037 2045.
72. Champagne P, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001 410: 106 111.
73. van Leeuwen EM Gamadia LE Baars PA Remmerswaal EB ten Berge IJ van Lier RA. Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells. J Immunol 2002 169: 5838 5843.
74. van Leeuwen EM van Buul JD Remmerswaal EB Hordijk PL ten Berge IJ van Lier RA. Functional re-expression of CCR7 on CMV-specific CD8+ T cells upon antigenic stimulation. Int Immunol 2005 17: 713 719.
75. de Bree GJ van Leeuwen EM Out TA Jansen HM Jonkers RE van Lier RA. Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. J Exp Med 2005 202: 1433 1442.
76. Baars PA, et al. Properties murine CD8(+)CD27(-) T Cells. Eur J Immunol 2005 35: 3131 3141.
77. Hamann D, et al. Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division. Int Immunol 1999 11: 1027 1033.
78. Wallace DL, et al. Direct measurement of T cell subset kinetics in vivo in elderly men and women. J Immunol 2004 173: 1787 1794.
79. van Baarle D, et al. Lack of Epstein-Barr virus- and HIV-specific CD27-CD8+ T cells is associated with progression to viral disease in HIV-infection. AIDS 2002 16: 2001 2011.
80. van Baarle D Kostense S Van Oers MH Hamann D Miedema F. Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue. Trends Immunol 2002 23: 586 591.
81. Cobbold M, et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 2005 202: 379 386.
82. Walter EA, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995 333: 1038 1044.
83. Lucas KG, et al. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants. Hum Gene Ther 2000 11: 1453 1463.
84. Powell DJ Dudley ME Robbins PF Rosenberg SA. Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood 2005 105: 241 250.
85. Lau LL Jamieson BD Somasundaram T Ahmed R. Cytotoxic T-cell memory without antigen. Nature 1994 369: 648 652.
86. Hou S Hyland L Ryan KW Portner A Doherty PC. Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature 1994 369: 652 654.
87. Becker TC, et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 2002 195: 1541 1548.
88. Rowley TF Al-Shamkhani A. Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo. J Immunol 2004 172: 6039 6046.
89. Couderc B, et al. Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells. Cancer Gene Ther 1998 5: 163 175.